The adenomatous polyposis coli (APC) gene located at 5q21–q22 encodes a tumor suppressor protein that acts as an antagonist of the Wnt/β-catenin pathway, which controls the CRC cell fate during the maintenance phase of tumors in patients [4, 5]. This evidence concerns the gene APC and colorectal carcinoma.